Two Sigma Advisers
SQZ

Two Sigma Advisers’s SQZ Biotechnologies Company SQZ Stock Holding History

Two Sigma Advisers’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-21,000
Closed -$101K – 2956
2022
Q1 		$101K Buy
21,000
+2,400
+13% +$15.2K ﹤0.01% 2504
2021
Q4 		$166K Buy
+18,600
New +$228K ﹤0.01% 2335

Other funds holding SQZ

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
N
NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Advisers's SQZ Position: Q2 2022 in Review

Two Sigma Advisers sold out of SQZ Biotechnologies Company (SQZ) in Q2 2022, closing a stake of 21,000 shares — an estimated $101K sold.

Two Sigma Advisers first reported a position in SQZ in Q4 2021 and held it in 2 quarters. The position peaked at $166K in Q4 2021. 53 funds tracked by Wall St. Rank hold SQZ as of Q2 2022.

  • Two Sigma Advisers reported no remaining SQZ Biotechnologies Company position as of Q2 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 21,000 SQZ Biotechnologies Company shares in Q2 2022, an estimated $101K.
  • Two Sigma Advisers first reported a position in SQZ Biotechnologies Company in Q4 2021 and held it in 2 quarters.
  • Two Sigma Advisers's SQZ Biotechnologies Company position peaked at $166K in Q4 2021.
  • 53 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q2 2022.

Based on Two Sigma Advisers's 13F filing for Q2 2022, filed 15 Aug 2022.